XML 60 R32.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Class A Common Stock [Member]
Common Stock [Member]
Class B Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Class B Common Stock [Member]
Total
Beginning balance at Feb. 03, 2020 $ 0 $ 0 $ 0 $ 0   $ 0
Beginning balance (in shares) at Feb. 03, 2020 0 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class B common stock to Sponsor [1],[2]   $ 1,035 23,965 0   25,000
Issuance of Class B common stock to Sponsor (in shares) [1],[2]   10,350,000        
Net loss   $ 0 0 (1,000)   (1,000)
Ending balance at Feb. 12, 2020   $ 1,035 23,965 (1,000) $ 24,000 24,000
Ending balance (in shares) at Feb. 12, 2020   10,350,000        
Beginning balance at Feb. 03, 2020 $ 0 $ 0 0 0   0
Beginning balance (in shares) at Feb. 03, 2020 0 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Class B common stock to Sponsor [3],[4]   $ 1,035 23,965 0   25,000
Issuance of Class B common stock to Sponsor (in shares) [3],[4]   10,350,000        
Net loss $ 0 $ 0 0 (1,000)   (1,000)
Ending balance at Mar. 31, 2020 $ 0 $ 1,035 23,965 (1,000)   24,000
Ending balance (in shares) at Mar. 31, 2020 0 10,350,000        
Beginning balance at Feb. 03, 2020 $ 0 $ 0 0 0   0
Beginning balance (in shares) at Feb. 03, 2020 0 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss           (391,135)
Ending balance at Sep. 30, 2020 $ 186 $ 1,035 5,389,917 (391,135)   5,000,003
Ending balance (in shares) at Sep. 30, 2020 1,857,799 10,350,000        
Beginning balance at Mar. 31, 2020 $ 0 $ 1,035 23,965 (1,000)   24,000
Beginning balance (in shares) at Mar. 31, 2020 0 10,350,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Sale of 41,400,000 Units, net of underwriting discounts $ 4,140   390,504,008 0   390,508,148
Sale of 41,400,000 Units, net of underwriting discounts (in shares) 41,400,000          
Sale of 6,853,333 Private Placement Warrants     10,280,000 0   10,280,000
Common stock subject to possible redemption $ (3,957)   (395,745,083) 0   (395,749,040)
Common stock subject to possible redemption (in shares) (39,574,904)          
Net loss $ 0 $ 0 0 (63,099)   (63,099)
Ending balance at Jun. 30, 2020 $ 183 $ 1,035 5,062,890 (64,099)   5,000,009
Ending balance (in shares) at Jun. 30, 2020 1,825,096 10,350,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in value of common stock subject to possible redemption $ 3   327,027 0   327,030
Change in value of common stock subject to possible redemption (in shares) 32,703          
Net loss $ 0 $ 0 0 (327,036)   (327,036)
Ending balance at Sep. 30, 2020 $ 186 $ 1,035 $ 5,389,917 $ (391,135)   $ 5,000,003
Ending balance (in shares) at Sep. 30, 2020 1,857,799 10,350,000        
[1] Includes 1,350,000 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.On May 20, 2020, the Company effected a stock dividend of 1,725,000 shares with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 10,350,000 Founder Shares. See Note 5.
[2] Includes up to 1,350,000 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.On May 20, 2020, the Company effected a stock dividend of 1,725,000 shares with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 10,350,000 Founder Shares. See Note 5.
[3] Included 1,350,000 shares of Class B common stock that were subject to forfeiture to the extent the over-allotment option was not exercised in full or in part by the underwriters (see Note 5).
[4] On May 20, 2020, the Company effected a stock dividend of 1,725,000 shares with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 10,350,000 Founder Shares (see Note 5).